| Nov 12, 2015 |
Nov 13, 2015 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
86.3
|
+25,000
|
8.29%
|
✗
|
$31.7K |
| Jun 9, 2015 |
Jun 9, 2015 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
78.8
|
+10,000
|
1.69%
|
✗
|
$15.3K |
| Mar 2, 2015 |
Mar 3, 2015 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
83.8
|
+10,029
|
3.56%
|
✗
|
$15.1K |
| Nov 1, 2013 |
Nov 5, 2013 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
86.3
|
+25,000
|
9.75%
|
✗
|
$13.3K |
| Nov 21, 2012 |
Nov 21, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+10,100
|
4.10%
|
✗
|
$4K |
| Nov 19, 2012 |
Nov 21, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
77.5
|
+4,800
|
1.99%
|
✗
|
$1.8K |
| Nov 16, 2012 |
Nov 21, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+35,100
|
17.01%
|
✗
|
$14.8K |
| Mar 20, 2012 |
May 10, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
85.0
|
+10,000
|
5.09%
|
✗
|
$5.2K |
| Feb 17, 2012 |
May 10, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+10,500
|
2.75%
|
✗
|
$5.7K |
| Dec 20, 2011 |
May 10, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+20,000
|
12.06%
|
✗
|
$13.6K |
| Nov 17, 2011 |
May 10, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+4,500
|
2.79%
|
✗
|
$3.6K |
| Mar 22, 2012 |
Apr 23, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
77.5
|
+10,000
|
1.25%
|
✗
|
$5.2K |
| Feb 17, 2011 |
Apr 23, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
85.0
|
+10,500
|
5.65%
|
✗
|
$5.7K |
| Dec 20, 2011 |
Apr 23, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+20,000
|
12.06%
|
✗
|
$13.6K |
| Nov 17, 2011 |
Apr 23, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+4,600
|
2.85%
|
✗
|
$3.7K |
| Mar 22, 2012 |
Mar 22, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
77.5
|
+10,000
|
1.49%
|
✗
|
$5.2K |
| Feb 17, 2012 |
Feb 22, 2012 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
85.0
|
+10,500
|
6.87%
|
✗
|
$5.7K |
| Dec 20, 2011 |
Dec 22, 2011 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+20,000
|
15.06%
|
✗
|
$13.6K |
| Nov 17, 2011 |
Nov 22, 2011 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+4,600
|
3.59%
|
✗
|
$3.7K |
| Mar 15, 2011 |
Mar 17, 2011 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+5,000
|
3.20%
|
✗
|
$5.3K |
| Mar 8, 2011 |
Mar 10, 2011 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
82.5
|
+4,600
|
3.03%
|
✗
|
$5.3K |
| Feb 23, 2011 |
Mar 1, 2011 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
91.3
|
+23,512
|
18.35%
|
✗
|
$30.5K |
| Feb 26, 2009 |
Mar 3, 2009 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
90.0
|
+47,654
|
59.19%
|
✗
|
$9.5K |
| Dec 10, 2008 |
Dec 23, 2008 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
90.0
|
+17,200
|
27.17%
|
✗
|
$3.9K |
| May 19, 2008 |
May 23, 2008 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
85.0
|
+5,000
|
8.58%
|
✗
|
$4.5K |
| May 19, 2008 |
May 19, 2008 |
Perspective Therapeutics, Inc.
|
CEO |
Buy |
85.0
|
+5,000
|
8.58%
|
✗
|
$4.5K |
| Sep 20, 2006 |
Sep 26, 2006 |
Perspective Therapeutics, Inc.
|
Director |
Buy |
91.3
|
+10,000
|
19.61%
|
✗
|
$28.5K |